Edition:
United States

Endo International PLC (ENDP.O)

ENDP.O on Nasdaq

3.50USD
17 Jul 2019
Change (% chg)

$-0.19 (-5.15%)
Prev Close
$3.69
Open
$3.72
Day's High
$3.76
Day's Low
$3.48
Volume
7,499,685
Avg. Vol
3,984,777
52-wk High
$18.50
52-wk Low
$3.48

About

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that... (more)

Overall

Beta: 1.15
Market Cap(Mil.): $834.61
Shares Outstanding(Mil.): 226.18
Dividend: --
Yield (%): --

Financials

  ENDP.O Industry Sector
P/E (TTM): -- 30.10 34.16
EPS (TTM): -2.10 -- --
ROI: -5.57 12.97 12.64
ROE: -- 14.18 17.19

Fed Circuit revives Endo patent on opioid Opana ER

Pharmaceutical company Endo International PLC on Thursday won a federal appeals court ruling that strengthens its patent protection on Opana ER, an opioid painkiller it pulled from the U.S. market in 2017.

Mar 28 2019

Endo gains on favorable FDA drug compounding decision

Endo International Plc said on Friday the U.S. health regulator has decided https://bit.ly/2XGrm1k not to include blood pressure treatment vasopressin in its list of drugs that can be used in compounding, in a boost to the drugmaker that makes the only FDA-approved version of the product.

Mar 01 2019

Endo gains on favorable FDA drug compounding decision

March 1 Endo International Plc said on Friday the U.S. health regulator has decided https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm632432.htm?utm_campaign=Compounding:%20FDA%20finalizes%20guidance%20on%20evaluating%20the%20clinical%20need%20for%20outsourcing&utm_medium=email&utm_source=Eloqua not to include blood pressure treatment vasopressin in its list of drugs that can be used in compounding, in a boost to the drugmaker that makes the only FDA-approved version of the produ

Mar 01 2019

Earnings vs. Estimates